G. Khachatryan, V. Omelyanovskiy, L. Melnikova, S. Ratushnyak
{"title":"Organizational structure and funding of health technology assessment agencies around the world","authors":"G. Khachatryan, V. Omelyanovskiy, L. Melnikova, S. Ratushnyak","doi":"10.17749/2070-4909.2019.12.2.146-154","DOIUrl":null,"url":null,"abstract":"Aim : analyze the structure and funding of health technology assessment (HTA) agencies abroad. Materials and methods . Here, we review the organizational structure and funding of HTA agencies in Europe (Austria, Belgium, Germany, Ireland, the Netherlands, the United Kingdom, France, and Sweden), Canada and Australia. The relevant information was found on web-sites of HTA agencies, in the Medline database, and via the searching engines Yandex and Google; the search was conducted using the specific descriptors: «organizational structure of HTA agency», «funding of HTA agency», «pharmaceutical», «reimbursement», «healthcare decision-making», and «funding». Results. The identified HTA-agencies may have a status of either government-funded or nonprofit organization or a structural element of a governmental body. These hTa agencies are funded mainly from the national budget. The funding varies from €550 000 for Ireland to £63.1 mln (€70 million) for the National Institute for Clinical Excellence (NICE) in the UK. The number of employees in the reviewed HTA agencies varies from 6.8 full time employees (FTE) in the Health Information and Quality Authority (HIQA) in Ireland to 604 FTEs in the NICE.","PeriodicalId":201824,"journal":{"name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17749/2070-4909.2019.12.2.146-154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:分析国外卫生技术评价机构的结构和经费来源。材料和方法。在这里,我们回顾了欧洲(奥地利、比利时、德国、爱尔兰、荷兰、英国、法国和瑞典)、加拿大和澳大利亚HTA机构的组织结构和资金。相关信息可通过HTA机构网站、Medline数据库以及Yandex和Google搜索引擎找到;搜索使用特定的描述符:“HTA机构的组织结构”、“HTA机构的资金”、“制药”、“报销”、“医疗保健决策”和“资金”。结果。已确定的卫生保健协会机构可能具有政府资助或非营利组织的地位,也可能具有政府机构的结构要素。这些人道主义援助机构的经费主要来自国家预算。资金从爱尔兰的55万欧元到英国国家临床卓越研究所(NICE)的6310万英镑(7000万欧元)不等。受审查的卫生保健机构的雇员人数各不相同,从爱尔兰卫生信息和质量管理局的6.8名全职雇员(FTE)到NICE的604名全职雇员。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Organizational structure and funding of health technology assessment agencies around the world
Aim : analyze the structure and funding of health technology assessment (HTA) agencies abroad. Materials and methods . Here, we review the organizational structure and funding of HTA agencies in Europe (Austria, Belgium, Germany, Ireland, the Netherlands, the United Kingdom, France, and Sweden), Canada and Australia. The relevant information was found on web-sites of HTA agencies, in the Medline database, and via the searching engines Yandex and Google; the search was conducted using the specific descriptors: «organizational structure of HTA agency», «funding of HTA agency», «pharmaceutical», «reimbursement», «healthcare decision-making», and «funding». Results. The identified HTA-agencies may have a status of either government-funded or nonprofit organization or a structural element of a governmental body. These hTa agencies are funded mainly from the national budget. The funding varies from €550 000 for Ireland to £63.1 mln (€70 million) for the National Institute for Clinical Excellence (NICE) in the UK. The number of employees in the reviewed HTA agencies varies from 6.8 full time employees (FTE) in the Health Information and Quality Authority (HIQA) in Ireland to 604 FTEs in the NICE.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries Systematic computer analysis of published literature on nutritional support for vaccination
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1